BrainScope is the only FDA cleared non-invasive medical device that objectively assesses head injured patients for both brain bleeds & concussions at point of care.
Demonstrated potential to reduce head CT in the ED by 31%
“Utilizing BrainScope gives me more actionable clinical data to assess concussion than is available to emergency physicians in the ED today."
Marsh Cuttino, MD FAAEM FACEP, Emergency Physician, Richmond VA
"When BrainScope is used independently or in conjunction with a standard head rule, fewer patients are scanned—resulting in less radiation exposure, less time in the ED, improved patient experience."
David Levine, MD, FACEP, Emergency Physician
“It answers the most pressing question when treating a potential traumatic brain injury...‘Does the patient have blood in his head or not?’ And, if the answer is no, then he can be discharged, and we can treat the next patient who’s waiting for care.”
Chief of Emergency Medicine, Level 1 Trauma
Naunheim R, Konstantinovic Koscso M, Poirier R. Reduction in unnecessary CT scans for head injury in the emergency department using an FDA cleared device. American Journal of Emergency Medicine. 2019 Oct;37(10):1987-1988. doi: 10.1016/j.ajem.2019.04.037
Article Info
Emergency Department (ED) visits for mild Traumatic Head Injury (mTBI) have greatly increased due to more awareness of potential consequences of such injuries. While the vast majority (>80%) of mTBI patients who go to the ED receive a head CT scan, >90% of them are found to be negative. This practice unnecessarily exposes these patients to radiation, increases the use of ED resources, and lengthens throughput times. The integration of reliable, objective predictors of intracranial injury for making important initial assessment decisions can impact significantly on this practice.
Confirm the likelihood of a brain bleed with 99% sensitivity to the smallest detectable level of blood (>1 mL).
Determine concussion status at same time with same setup and recording.
A patient with mild traumatic brain injury is a person who has had a traumatically induced physiological disruption of brain function, as manifested by at least one of the following:
1. Any period of loss of consciousness;
2. Any loss of memory for events immediately before or after the accident;
3. Any alteration in mental state at the time of the accident (e.g., feeling dazed, disoriented, or confused); and
4. Focal neurological deficit(s) that may or may not be transient; but where the severity of the injury does not exceed the following: loss of consciousness of approximately 30 minutes or less; after 30 minutes, an initial Glasgow Coma Scale (GCS) of 13–15; and post traumatic amnesia (PTA) not greater than 24 hours.
This definition includes:
1. The head being struck,
2. The head striking an object, and
3. The brain undergoing an acceleration/deceleration movement (i.e., whiplash) without direct external trauma to the head.
Ref : www.acrm.org
FDA cleared A.I. derived algorithms assess 10,000 EEG features and employ age regression and advanced pattern recognition to determine the likelihood of structural and functional brain injury with high independently validated accuracy.
Hanley D, Prichep LS, Badjatia N, Bazarian J, Chiacchierini R, Curley K, Garrett J, Jones E, Naunheim R, O'Neil B, O'Neill J, Wright DW, Huff JS. A Brain Electrical Activity (EEG) Based Biomarker of Functional Impairment in Traumatic Head Injury: A Multisite Validation Trial. Journal of Neurotrauma. 2018; 35(1):41-47.
Hanley D, Prichep LS, Bazarian J, Huff JS, Naunheim R, Garrett J, Jones E, Wright DW, O'Neill J, Badjatia N, Gandhi D, Curley K, Chiacchierini R, O'Neil B, Hack D. Emergency Department Triage of Traumatic Head Injury Using Brain Electrical Activity Biomarkers: A Multisite Prospective Observational Validation Trial. Academic Emergency Medicine. 2017; 24(5):617-627.
Click here for a complete list of indications